Equillium (EQ) Net Cash Flow Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 198.34% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 467.41% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -14,223.53% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 453.08% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -125.22% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 53.46% |
| 10 | Equillium | 279.21 Mn | 218.82 Mn | - | 966.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 966.61% |
| Dec 31, 2025 | -204.04% |
| Sep 30, 2025 | 398.23% |
| Jun 30, 2025 | -387.76% |
| Mar 31, 2025 | 69.20% |
| Dec 31, 2024 | 124.84% |
| Sep 30, 2024 | -50.74% |
| Jun 30, 2024 | -153.21% |
| Mar 31, 2024 | 66.39% |
| Dec 31, 2023 | -133.44% |
| Sep 30, 2023 | 355.61% |
| Jun 30, 2023 | 145.44% |
| Mar 31, 2023 | -43.48% |
| Dec 31, 2022 | 224.44% |
| Sep 30, 2022 | -46.72% |
| Jun 30, 2022 | -111.33% |
| Mar 31, 2022 | -189.73% |
| Dec 31, 2021 | -6.01% |
| Sep 30, 2021 | -85.54% |
| Jun 30, 2021 | 553.15% |
| Mar 31, 2021 | 262.75% |
| Dec 31, 2020 | -74.72% |
| Sep 30, 2020 | 610.59% |
| Jun 30, 2020 | 170.33% |
| Mar 31, 2020 | 204.15% |
| Dec 31, 2019 | -161.50% |
| Sep 30, 2019 | -199.33% |
| Jun 30, 2019 | 208.26% |
| Mar 31, 2019 | -695.86% |